BioMed Partners and High-Tech Gründerfonds (HTGF) have co-led a €10.7m round for Germany-based Tubulis, a developer of antibody-drug conjugates (ADC).
BioMed Partners and HTGF lead €10.7m round for Tubulis
Most Popular
BioMed Partners and High-Tech Gründerfonds (HTGF) have co-led a €10.7m round for Germany-based Tubulis, a developer of antibody-drug conjugates (ADC).